search
Back to results

Bowel Preparation for Magnetic Resonance Enterography

Primary Purpose

Crohn Disease

Status
Completed
Phase
Not Applicable
Locations
China
Study Type
Interventional
Intervention
mid-gut tubing
Sponsored by
The Second Hospital of Nanjing Medical University
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional supportive care trial for Crohn Disease focused on measuring magnetic resonance enterography, bowel preparation

Eligibility Criteria

14 Years - undefined (Child, Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Patients with CD need MRE examination and mid-gut tubing (prepared for fecal microbiota transplantation and/or enteral nutrition);
  • Age ≥ 14 years old.

Exclusion Criteria:

  • Unable to understand or provide informed consent;
  • Had difficulty in swallowing, or dysphagia;
  • Allergic to laxative and/or contrast;
  • Claustrophobia or implanted metal objects or cardiac pacemaker precluding performance of MRI;
  • Known or suspected intestinal obstruction or severe stricture.

Sites / Locations

  • Fmt-Dt-N-27/1350

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

No Intervention

Arm Label

Tubing-group

Oral-group

Arm Description

mid-gut tubing prior to the MRE examination, administer contrast solution through the mid-gut tube

administer contrast solution orally, mid-gut tubing after the MRE examination

Outcomes

Primary Outcome Measures

grade of bowel distention
grade of bowel distention evaluated by a 5-grade scale (1 = 0-20% segmental distention, 2 = 20-40% distention, 3 = 40-60% distention, 4 = 60-80% distention, 5 = 80-100% distention)
degree of discomfort
using a visual 5-grade to describe the severity of nervousness, nausea, vomiting, bloating, abdominal pain, and diarrhea (1 = few, 5 = very severe)

Secondary Outcome Measures

accuracy of lesion detection
accuracy of lesion detection through MRE confirmed by endoscopy (within 1 month before MRE and during this hospitalization) will be evaluated by a 5-point scale (lesions locating at the terminal ileum, ileocecal junction, hepatic flexure of colon, splenic flexure of colon, and rectosigmoid colon, consistency of lesion detection from each bowel segment scoring 1 point, otherwise not scoring)

Full Information

First Posted
May 5, 2018
Last Updated
April 3, 2023
Sponsor
The Second Hospital of Nanjing Medical University
Collaborators
Wuxi No. 2 People's Hospital
search

1. Study Identification

Unique Protocol Identification Number
NCT03541733
Brief Title
Bowel Preparation for Magnetic Resonance Enterography
Official Title
The Bowel Preparation for Magnetic Resonance Enterography: a Open Label, Multicenter Randomized Controlled Trial
Study Type
Interventional

2. Study Status

Record Verification Date
April 2023
Overall Recruitment Status
Completed
Study Start Date
June 1, 2018 (Actual)
Primary Completion Date
February 28, 2023 (Actual)
Study Completion Date
February 28, 2023 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
The Second Hospital of Nanjing Medical University
Collaborators
Wuxi No. 2 People's Hospital

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
Yes

5. Study Description

Brief Summary
Adequate bowel preparation is required for magnetic resonance enterography (MRE) which can be achieved by two methods including administering contrast solution after mid-gut tubing and taking contrast solution orally. We present the design of randomized controlled trial to compare the efficacy and compliance of bowel preparation through mid-gut tubing with taking contrast orally for MRE in patients with Crohn's disease (CD).
Detailed Description
This is a open label, multicenter, randomized controlled trial. 96 patients are planed to be 1:1 randomized into one of two groups: (1) Tube group, mid-gut tubing prior to the MRE examination, administer contrast solution through the mid-gut tube; (2) Oral group, administer contrast solution orally, mid-gut tubing after the MRE examination. The primary outcome measures are: (1) grade of bowel distention evaluated by a 5-grade scale (1 = 0-20% segmental distention, 2 = 20-40% distention, 3 = 40-60% distention, 4 = 60-80% distention, 5 = 80-100% distention); (2) degree of discomfort before/during/after bowel preparation for MRE using a visual 5-grade to describe the severity of nervousness, nausea, vomiting, bloating, abdominal pain, and diarrhea (1 = few, 5 = very severe). The secondary outcome measure is the accuracy of lesion detection through MRE confirmed by endoscopy (within 1 month before MRE and during this hospitalization) will be evaluated by a 5-point scale (lesions locating at the terminal ileum, ileocecal junction, hepatic flexure of colon, splenic flexure of colon, and rectosigmoid colon, consistency of lesion detection from each bowel segment scoring 1 point, otherwise not scoring).

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Crohn Disease
Keywords
magnetic resonance enterography, bowel preparation

7. Study Design

Primary Purpose
Supportive Care
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
102 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Tubing-group
Arm Type
Experimental
Arm Description
mid-gut tubing prior to the MRE examination, administer contrast solution through the mid-gut tube
Arm Title
Oral-group
Arm Type
No Intervention
Arm Description
administer contrast solution orally, mid-gut tubing after the MRE examination
Intervention Type
Other
Intervention Name(s)
mid-gut tubing
Intervention Description
mid-gut tubing at different time
Primary Outcome Measure Information:
Title
grade of bowel distention
Description
grade of bowel distention evaluated by a 5-grade scale (1 = 0-20% segmental distention, 2 = 20-40% distention, 3 = 40-60% distention, 4 = 60-80% distention, 5 = 80-100% distention)
Time Frame
one year
Title
degree of discomfort
Description
using a visual 5-grade to describe the severity of nervousness, nausea, vomiting, bloating, abdominal pain, and diarrhea (1 = few, 5 = very severe)
Time Frame
one year
Secondary Outcome Measure Information:
Title
accuracy of lesion detection
Description
accuracy of lesion detection through MRE confirmed by endoscopy (within 1 month before MRE and during this hospitalization) will be evaluated by a 5-point scale (lesions locating at the terminal ileum, ileocecal junction, hepatic flexure of colon, splenic flexure of colon, and rectosigmoid colon, consistency of lesion detection from each bowel segment scoring 1 point, otherwise not scoring)
Time Frame
one year

10. Eligibility

Sex
All
Minimum Age & Unit of Time
14 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Patients with CD need MRE examination and mid-gut tubing (prepared for fecal microbiota transplantation and/or enteral nutrition); Age ≥ 14 years old. Exclusion Criteria: Unable to understand or provide informed consent; Had difficulty in swallowing, or dysphagia; Allergic to laxative and/or contrast; Claustrophobia or implanted metal objects or cardiac pacemaker precluding performance of MRI; Known or suspected intestinal obstruction or severe stricture.
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Faming Zhang, MD, PhD
Organizational Affiliation
The Second Hospital of Nanjing Medical University
Official's Role
Principal Investigator
Facility Information:
Facility Name
Fmt-Dt-N-27/1350
City
Nanjing
State/Province
Jiangsu
ZIP/Postal Code
210011
Country
China

12. IPD Sharing Statement

Plan to Share IPD
Undecided
Citations:
PubMed Identifier
14634782
Citation
Ajaj W, Goehde SC, Schneemann H, Ruehm SG, Debatin JF, Lauenstein TC. Oral contrast agents for small bowel MRI: comparison of different additives to optimize bowel distension. Eur Radiol. 2004 Mar;14(3):458-64. doi: 10.1007/s00330-003-2177-0. Epub 2003 Nov 22.
Results Reference
background
PubMed Identifier
25168749
Citation
Cui B, Feng Q, Wang H, Wang M, Peng Z, Li P, Huang G, Liu Z, Wu P, Fan Z, Ji G, Wang X, Wu K, Fan D, Zhang F. Fecal microbiota transplantation through mid-gut for refractory Crohn's disease: safety, feasibility, and efficacy trial results. J Gastroenterol Hepatol. 2015 Jan;30(1):51-8. doi: 10.1111/jgh.12727.
Results Reference
background
PubMed Identifier
17899102
Citation
Masselli G, Casciani E, Polettini E, Gualdi G. Comparison of MR enteroclysis with MR enterography and conventional enteroclysis in patients with Crohn's disease. Eur Radiol. 2008 Mar;18(3):438-47. doi: 10.1007/s00330-007-0763-2. Epub 2007 Sep 25.
Results Reference
background
PubMed Identifier
17483955
Citation
Negaard A, Paulsen V, Sandvik L, Berstad AE, Borthne A, Try K, Lygren I, Storaas T, Klow NE. A prospective randomized comparison between two MRI studies of the small bowel in Crohn's disease, the oral contrast method and MR enteroclysis. Eur Radiol. 2007 Sep;17(9):2294-301. doi: 10.1007/s00330-007-0648-4. Epub 2007 May 5.
Results Reference
background
PubMed Identifier
29534703
Citation
Long C, Yu Y, Cui B, Jagessar SAR, Zhang J, Ji G, Huang G, Zhang F. A novel quick transendoscopic enteral tubing in mid-gut: technique and training with video. BMC Gastroenterol. 2018 Mar 13;18(1):37. doi: 10.1186/s12876-018-0766-2.
Results Reference
background
PubMed Identifier
30606236
Citation
Dai M, Zhang T, Li Q, Cui B, Xiang L, Ding X, Rong R, Bai J, Zhu J, Zhang F. The bowel preparation for magnetic resonance enterography in patients with Crohn's disease: study protocol for a randomized controlled trial. Trials. 2019 Jan 3;20(1):1. doi: 10.1186/s13063-018-3101-x.
Results Reference
derived

Learn more about this trial

Bowel Preparation for Magnetic Resonance Enterography

We'll reach out to this number within 24 hrs